Skip to main content
Premium Trial:

Request an Annual Quote

HalioDx Brightplex

HalioDx launched Brightplex, a high-capacity immunohistochemistry multiplex technology for analyzing multiple biomarkers on a single formalin-fixed, paraffin-embedded slide. The first panel, Brightplex TCE, uses five biomarkers to identify exhaused T cells. The second panel, Brightplex MDSC, combines six biomarkers to identify different subtypes of myeloid-derived suppressor cells that have been difficult to identify by IHC. Additional panels will be developed based on the Brightplex technology, HalioDx said.